Ads
related to: programmed cell death
Search results
Gilead (GILD), RCUS Announce Data From Colorectal Cancer Study
Zacks via Yahoo Finance· 13 hours agoEtrumadenant is an investigational small molecule, selective dual antagonist of the A2a and A2b...
ASCO 2024: AbbVie flexes early success of ADC pipeline in solid tumours
Clinical Trials Arena via Yahoo Finance· 23 hours agoABBV-706 is an ADC targeting SEZ6, a transmembrane protein expressed in various solid tumours,...
Are You Getting Enough Iodine From Your Diet?
Mercola· 7 hours agoUnfortunately, data collected by the U.S. National Health and Nutrition Examination Survey has revealed a significant drop in median urine iodine values.1 The median iodine level measured in ...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 2 hours agoLive from ASCO 2024 | Updated Data of Bcl-2 Inhibitor Lisaftoclax Combined with Azacitidine in Patients with AML Demonstrate Promising Efficacy and Manageable Safety PR Newswire SUZHOU, China ...
A Deeper Look at Anti-PD-1/PD-L1 Checkpoint Inhibitors for Cancer
Forbes· 4 days agoIn a previous story, I described pembrolizumab, a PD-1 targeting checkpoint inhibitor, in some...
Pipeline Moves: Phase III AML trial fails to meet primary endpoint
Clinical Trials Arena via Yahoo Finance· 7 days agoEpimAb Biotherapeutics’ had originally anticipated enrolling 43 patients. The trial was terminated...
EMA Panel Nods to Seven New Cancer Drugs
Medscape· 4 days agoThe drugs include an anti–PD-L1 monoclonal antibody, a biosimilar, and five generics, with indications covering a wide spectrum of cancers.
Exploring the potential of dietary phytochemicals in cancer prevention
Medical Xpress· 4 days agoCancer remains a significant global health challenge and is a leading cause of mortality worldwide....
Upregulation of rate-limiting enzymes in cholesterol metabolism by PKCδ mediates endothelial...
Nature· 6 days agoDiabetic foot ulcer (DFU) is a prevalent complication of diabetes that poses significant challenges in terms of treatment and management. It is characterized by heightened endothelial apoptosis ...
Gilead and Arcus Announce Etrumadenant Plus Zimberelimab Regimen Significantly Reduced the Risk of...
Morningstar· 2 days agoGilead and Arcus Announce EtrumadenantPlus Zimberelimab Regimen Significantly Reduced the Risk of Death in Third-line Metastatic Colorectal Cancer – In Cohort B of the ARC-9 mCRC Study, Etrumadenant ...